minimus
Senior Member
- Messages
- 140
- Location
- New York, NY
I spoke to Cheney last week about my experience with GcMAF so far. I have taken 5 doses and have noticed no flu-like (IRIS) symptoms. He said that so far the people who benefit from GcMAF have a pronounced flu-like syndrome after the third dose (about 10-14 days after the first dose) that usually lasts for a week or two. He said that patients with the BB phenotype in his practice are much less likely to respond positively to GcMAF than those who are bb or Bb. Turns out I am BB phenotype, which also may explain why I am not really seeing any effect from GcMAF (flu-like symptoms followed by functional improvement). He says one's Fok-l status (FF, Ff, ff) seems so far to not be particularly relevant in predicting response to GcMAF. Overall, fairly discouraging for me.
He said he is trying to work out changes to the protocol that might lower chances of non-response among the BB phenotype patients, but this would be somewhat experimental at this point and would involve a lot of time consulting with him on the phone as well as added expense of extra lab tests. In other words, he is willing to work with his non-responder patients to see if he can get GcMAF to work, but these patients would be sort of like guinea pigs. And they would have to pay for his time and for additional testing. I suspect he will try to work this through to the best of his ability, but he admitted there is some chance that non-responders will remain non-responders regardless of protocol.
He said he is trying to work out changes to the protocol that might lower chances of non-response among the BB phenotype patients, but this would be somewhat experimental at this point and would involve a lot of time consulting with him on the phone as well as added expense of extra lab tests. In other words, he is willing to work with his non-responder patients to see if he can get GcMAF to work, but these patients would be sort of like guinea pigs. And they would have to pay for his time and for additional testing. I suspect he will try to work this through to the best of his ability, but he admitted there is some chance that non-responders will remain non-responders regardless of protocol.